Search hospitals > Florida > Tampa
Tampa General Hospital
Claim this profileTampa, Florida 33606
Global Leader in Tumors
Global Leader in Cancer
Conducts research for Leukemia
Conducts research for Heart Failure
Conducts research for Lymphoma
353 reported clinical trials
34 medical researchers
Summary
Tampa General Hospital is a medical facility located in Tampa, Florida. This center is recognized for care of Tumors, Cancer, Leukemia, Heart Failure, Lymphoma and other specialties. Tampa General Hospital is involved with conducting 353 clinical trials across 547 conditions. There are 34 research doctors associated with this hospital, such as Juan F. Rico, Andrew J. Galligan, Maxim Mokin, PhD, and Sajeel A. Chowdhary.Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Cancer
Global LeaderStage I
Stage IV
Stage II
Top PIs
Juan F. RicoTampa General Hospital7 years of reported clinical research
Expert in Tumors
Studies Cancer
29 reported clinical trials
80 drugs studied
Andrew J. GalliganTampa General Hospital7 years of reported clinical research
Expert in Tumors
Studies Lymphoma
25 reported clinical trials
71 drugs studied
Maxim Mokin, PhDTampa General Hospital3 years of reported clinical research
Studies Stroke
Studies Ischemic Stroke
7 reported clinical trials
12 drugs studied
Sajeel A. ChowdharyBoca Raton Regional Hospital7 years of reported clinical research
Studies Glioblastoma
Studies Cancer
7 reported clinical trials
16 drugs studied
Clinical Trials running at Tampa General Hospital
Breast Cancer
Osteosarcoma
Non-Hodgkin's Lymphoma
Anal Cancer
Heart Failure
Brain Tumor
Cancer
Ovarian Cancer
Ovarian Tumors
Lymphoma
Giredestrant + Everolimus
for Advanced or Metastatic Breast Cancer
This trial is testing if a combination of giredestrant and everolimus works better than other hormone treatments plus everolimus in patients with advanced breast cancer who have already tried other treatments. The drugs work by blocking estrogen receptors and a growth pathway in cancer cells. Everolimus has been shown to improve outcomes in breast cancer patients when combined with hormonal treatments.
Recruiting2 awards Phase 37 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Tampa General Hospital?
Tampa General Hospital is a medical facility located in Tampa, Florida. This center is recognized for care of Tumors, Cancer, Leukemia, Heart Failure, Lymphoma and other specialties. Tampa General Hospital is involved with conducting 353 clinical trials across 547 conditions. There are 34 research doctors associated with this hospital, such as Juan F. Rico, Andrew J. Galligan, Maxim Mokin, PhD, and Sajeel A. Chowdhary.
Where is Tampa General Hospital located?
**Directions to Tampa General Hospital, Tampa, Florida:**
- From I-275, exit at 44 or 45A.
- Follow signs for Ashley Dr., then turn right onto Kennedy Blvd.
- Look for Hospital (H) signs and turn left onto S. Hyde Park Ave. to arrive at the hospital.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Tampa General Hospital, contact the following departments:
- **Patient Financial Assistance**: For estimates on hospital services, call 813-844-8084, Monday - Friday, 8 a.m. - 4:30 p.m.
- **Billing & Insurance**: Email mybill@tgh.org or call 813-844-7291, Monday - Friday, 8 a.m. - 4:30 p.m.
- **MyChart Users**: Submit billing questions via MyChart by clicking “Billing” then “See Account Detail”.
For insurance-specific inquiries, contact your insurance provider using the phone number on your billing notice.
What insurance does Tampa General Hospital accept?
Tampa General Hospital accepts a wide range of insurance plans, including but not limited to Medicare Supplement plans, commercial plans (e.g., Florida Hospital Healthcare System, Holland America Cruise Line, Private Healthcare Systems, Inc.), Medicare Advantage Plans (e.g., BaycarePlus Medicare Advantage), Governmental Payors (e.g., Hillsborough County Health Plan, Humana Military Healthcare Services), Health Exchange Plans (e.g., Molina Healthcare of Florida, Inc.), and Medicaid HMO Plans (e.g., Molina Healthcare of Florida, Inc., Magellan Complete Care of Florida). They are committed to transparency in coverage, offering detailed cost information for both in-network and out-of-network healthcare services on their website.
What awards or recognition has Tampa General Hospital received?
Tampa General Hospital is celebrated for its excellence, featuring on the 2022 Fortune/Merative 100 Top Hospitals list. It has been acknowledged by Newsweek as one of America's Greatest Workplaces for Women and Diversity in 2023. Additionally, it has earned the Collaborative Just Culture Program® recognition, highlighting its dedication to patient safety and high-quality healthcare.